Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation.
Cantarovich, D
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation. [electronic resource] - Transplantation Jan 1994 - 198-203 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0041-1337
10.1097/00007890-199401001-00007 doi
Acute Disease
Adult
Antibodies, Monoclonal--therapeutic use
Antilymphocyte Serum--administration & dosage
Diabetes Mellitus, Type 1--surgery
Female
Follow-Up Studies
Graft Rejection--prevention & control
Graft Survival
Humans
Immunosuppression Therapy
Kidney Transplantation--physiology
Male
Middle Aged
Pancreas Transplantation--physiology
Prospective Studies
Receptors, Interleukin-2--immunology
T-Lymphocytes--immunology
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation. [electronic resource] - Transplantation Jan 1994 - 198-203 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0041-1337
10.1097/00007890-199401001-00007 doi
Acute Disease
Adult
Antibodies, Monoclonal--therapeutic use
Antilymphocyte Serum--administration & dosage
Diabetes Mellitus, Type 1--surgery
Female
Follow-Up Studies
Graft Rejection--prevention & control
Graft Survival
Humans
Immunosuppression Therapy
Kidney Transplantation--physiology
Male
Middle Aged
Pancreas Transplantation--physiology
Prospective Studies
Receptors, Interleukin-2--immunology
T-Lymphocytes--immunology